Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
- PMID: 36751674
- PMCID: PMC9790091
- DOI: 10.1183/23120541.00389-2022
Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
Abstract
In situ pulmonary arterial thrombosis in COVID-19 is not visible on CTPA. However, the presence of CT-measured right heart and pulmonary artery dilatation in COVID-19 is likely attributable to this process and may be a possible surrogate for its detection. https://bit.ly/3g7z5TV.
Copyright ©The authors 2023.
Conflict of interest statement
Conflict of interest: L.C. Price has received support from Janssen Pharmaceuticals and Ferrer Pharmaceuticals to attend meetings outside the submitted work, and participated on a data safety or advisory board for Janssen outside the submitted work. The remaining authors have nothing to disclose.
References
-
- World Health Organisation . WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int Date last accessed: 20 February 2021.
LinkOut - more resources
Full Text Sources